Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) EBT Margin: 2019-2024

Historic EBT Margin for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to -9.76%.

  • Eton Pharmaceuticals' EBT Margin fell 1356.00% to -8.70% in Q3 2025 from the same period last year, while for Sep 2025 it was -11.83%, marking a year-over-year decrease of 254.00%. This contributed to the annual value of -9.76% for FY2024, which is 758.00% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported EBT Margin of -9.76% as of FY2024, which was down 348.29% from -2.18% recorded in FY2023.
  • Eton Pharmaceuticals' EBT Margin's 5-year high stood at -2.18% during FY2023, with a 5-year trough of -71,717.95% in FY2020.
  • Its 3-year average for EBT Margin is -18.13%, with a median of -9.76% in 2024.
  • Per our database at Business Quant, Eton Pharmaceuticals' EBT Margin crashed by 6,980,763bps in 2020 and then soared by 7,170,899bps in 2021.
  • Eton Pharmaceuticals' EBT Margin (Yearly) stood at -71,717.95% in 2020, then soared by 7,170,899bps to -8.95% in 2021, then plummeted by 3,350bps to -42.45% in 2022, then spiked by 4,027bps to -2.18% in 2023, then plummeted by 758bps to -9.76% in 2024.